BNP Paribas Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
BNP Paribas Asset Management's HALO Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its Halozyme (HALO) stake by 1.8% in Q2 2026, selling an estimated $150K and leaving 120,137 shares worth $9.4M. The position accounts for 0.01% of the portfolio, ranked #751.
BNP Paribas Asset Management first reported a position in HALO in Q2 2021 and has held it in 6 quarters since. The position peaked at $9.89M in Q4 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- BNP Paribas Asset Management held 120,137 shares of Halozyme worth $9.4M as of Q2 2026.
- BNP Paribas Asset Management sold 2,193 Halozyme shares in Q2 2026, an estimated $150K.
- Halozyme made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #751 holding.
- BNP Paribas Asset Management first reported a position in Halozyme in Q2 2021 and has held it in 6 quarters since.
- BNP Paribas Asset Management's Halozyme position peaked at $9.89M in Q4 2025.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.